3 completed, 1 terminated, 1 unknown. 3 Phase 2, 1 Early Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 1, Terminated 1, Unknown 1 |
| Early Phase 1 | 1 | Completed 1 |
Follow Molecular Targeted Therapy: new trials by email Literature Review of Molecular Targeted Therapy trials Research Report on Molecular Targeted Therapy
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| The Role of Brain Radiotherapy in Patients With Asymptomatic Brain Metastasis in the Era of Targeted Therapy for NSCLC molecular targeted therapies, Brain Radiotherapy - Non Small Cell Lung Cancer, Brain Metastases | Phase 2 | Unknown | Second Affiliated Hospital of Nanchang University | 100 | 2019-12-01 | 2019-12-10 |
| Trajectory-Based Prognostic Modeling in Hepatocellular Carcinoma Molecular Targeted Therapy (TKI / anti-VEGF antibody) PD-(L)1 Inhibitor Immunotherapy Interventional Therapy (TACE / HAIC) - Liver Cancer | Completed | Xu Yong, MD | 379 | 2018-01-01 | 2025-10-02 | |
| NU-0129 in Treating Patients With Recurrent Glioblastoma or Gliosarcoma Undergoing Surgery Laboratory Biomarker Analysis, Pharmacological Study, Targeted Molecular Therapy - Gliosarcoma, Recurrent Glioblastoma | Early Phase 1 | Completed | Northwestern University | 8 | 2017-05-25 | 2022-08-26 |
| Targeted Therapy in Treating Patients With Incurable Non-Small Cell Lung Cancer With Genetic Mutations Chemotherapy, Immunotherapy, Laboratory Biomarker Analysis - EGFR Activating Mutation, Recurrent Non-Small Cell Lung Carcinoma | Phase 2 | Terminated | Wake Forest University Health Sciences | 19 | 2017-03-10 | 2024-06-28 |
| Molecularly Targeted Therapy in Treating Patients With BRAF Wild-type Melanoma That is Metastatic cytology specimen collection procedure, MEK 162 therapy or molecularly targeted therapy, therapeutic procedure - Recurrent Melanoma, Stage IIIA Melanoma | Phase 2 | Completed | Yale University | 49 | 2014-05-01 | 2020-01-02 |
Carcinoma, Non-Small-Cell Lung (2) · Brain Neoplasms (1) · Glioblastoma (1) · Gliosarcoma (1) · Liver Neoplasms (1) · Melanoma (1)
Northwestern University (1) · Second Affiliated Hospital of Nanchang University (1) · Wake Forest University Health Sciences (1) · Xu Yong, MD (1) · Yale University (1)
United States (3) · China (2)
Liu Anwen, Phd (1) · Patricia LoRusso, D.O. (1) · Priya Kumthekar, MD (1) · William Petty (1) · Yong Xu, Dr (1)
PMID 11452123, PMID 12750523, PMID 16757720, PMID 17229875, PMID 19801201, PMID 21041710, PMID 21472002, PMID 22012633, PMID 22134072, PMID 23129122, PMID 24021541, PMID 24419416, PMID 26148750, PMID 26823294, PMID 27343440, PMID 27458945, PMID 28126333
P30CA012197 (1), P30CA022453 (1), P30CA060553 (1)